8-K1.019.01
8-K exhibit
EDGARDrugs Made In America Acquisition Corp. Rights
Drugs Made In America Acquisition Corp. Rights (DMAAR) SEC filings
Drugs Made In America Acquisition Corp. Rights (DMAAR) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Net income was $2.2M. DMAAR currently screens at market cap $1.8M. The DMAAR filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Drugs Made In America Acquisition Corp. Rights said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
1
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all DMAAR filings.
Frequently asked questions
What did DMAAR just say?
DMAAR cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are DMAAR SEC filings?
1 cached filing is on this page. EDGAR remains the official archive (CIK 0002028614).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.